(Q87148953)
Statements
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS (English)
Fred D Lublin
Gavin Giovannoni
Amy Pace
Nolan R Campbell
6 September 2014
scientific article published on 06 September 2014